Primary Record
CYCLOPAMINE
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,590 g
- Purity
- 99.5 %
- CAS
- 4449-51-8
Compound Identifiers & Properties
- CAS
- 4449-51-8
- PubChem CID
- 442972
- SMILES
- C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1
- Canonical SMILES
- CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C
Names & Synonyms
- CYCLOPAMINE
- 11-Deoxojervine
- 11-Deoxyjervine
- 4449-51-8
- Alkaloid V
- Cyclopamine Tartrate
- Jervine, 11-deoxo-
- ? 11-Deoxojervine
- 3,4'-Dinitroflavone
- CYCLOPAMINE?
- Cyclopamine (Standard)
- Cyclopamine, Free Base
- DTXSID6043709
- AC1L9DRQ
- CYCLOPAMINE [MI]
- RefChem:129819
- CYCLOPAMINE [HSDB]
- D05UKJ
- UNII-ZH658AJ192
- CHEMBL254129
- QASFUMOKHFSJGL-LAFRSMQTSA-N
- ZH658AJ192
- MFCD09878269
- SCHEMBL29153
- BSPBio_001032
- DTXCID4023709
- HSDB 3505
- MLS006010945
- CHEBI:4021
- NSC-734950
- C27H41NO2
- GTPL10328
- HSDB-3505
- AOB1606
- EX-A952
- BCPP000271
- GLXC-02575
- HMS1792D13
- HMS1990D13
- HMS3403D13
- 11-deoxojervine, 4449-51-8
- ZINC4098868
- Tox21_300632
- BBF-03880
- BDBM50232973
- C27-H41-N-O2
- CID442972
- HB2965
- HY-17024R
- MSK001551
- NSC734950
- s1146
- AKOS024456709
- (3beta23R)-17,23-Epoxyveratraman-3-ol
- ACN-035433
- BCP9000568
- CCG-208181
- CID:442972
- CS-0633
- EBC-373054
- FC20718
- NSC 734950
- NCGC00163474-03
- NCGC00163474-04
- NCGC00163474-07
- NCGC00254431-01
- AC-34305
- BC658524
- HY-17024
- SID:53790549
- SMR001822854
- CAS-4449-51-8
- AB0007896
- Veratraman-3-ol, 17,23-epoxy-, (3beta,23beta)-
- A8340
- FT-0624245
- FT-0776630
- 6832-EP2316832A1
- 6832-EP2316833A1
- C10798
- F16272
- W-5421
- Cyclopamine11-Deoxyjervine; Jervine, 11-deoxo-
- A826604
- C000541
- SR-05000002357
- Veratraman-3-ol,23-epoxy-, (3-beta,23-beta)-
- Q3271319
- SR-05000002357-2
- (22S,23R)-17beta-17,23-Epoxyveratraman-3beta-ol
- BRD-K58938839-001-03-8
- Veratraman-3-ol, 17,23-epoxy-, (3-beta,23-beta)-
- Z3243808232
- Veratraman-3-ol, 17,23-epoxy-, (3.beta.,23.beta.)-
- (3alpha,8alpha,14beta,22S,23R)-17,23-epoxyveratraman-3-ol
- (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethylspiro[2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-ol
- Cyclopamine, 98%, from Veratrum californicum Durand - 1MG 1mg
- (2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11,11a,11b-octadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-3-ol
- Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)- (9CI)
- (1'S,2R,2'R,3R,3aS,5'S,6S,7aR,10'S,11'S)-2',3,6,15'-tetramethyl-3a,4,5,6,7,7a-hexahydro-3H-spiro(furo(3,2-b)pyridine-2,14'-tetracyclo(8.7.0.02,7.011,16)heptadecane)-7',15'-dien-5'-ol
- (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro(9H-benzo(a)fluorene-9,2'(3'H)-furo(3,2-b)pyridin)-3-ol
- (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol
- (2?R,3S,3?R,3?aS,6?S,6aS,6bS,7?aR,11aS,11bR)-1,2,3,3?a,4,4?,5?,6,6?,6a,6b,7,7?,7?a,8,11,11a,11b-Octadecahydro-3?,6?,10,11b-tetrameth ylspiro[9H-benzo[a]fluorene-9,2?(3?H)-furo[3,2-b]pyridin]-3-ol
- (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3'H-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridin]-3-ol
- (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethyl-2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a-hexadecahydro-1H,3'H-spiro[cyclohexa[a]fluorene-9,2'-furo[3,2-b]pyridine]-3-ol
- (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethylspiro(2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo(a)fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo(3,2-b)pyridine)-3-ol
- (3S,3'R,3a'S,6aS,6bS,6'S,7a'R,9R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11,11a,11b-octadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-3-
- 11051-96-0
- 1178510-81-0
- 628-058-8
- CY8
- ol
- Spiro(9H-benzo(a)fluorene-9,2'(3'H)-furo(3,2-b)pyridin)-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-
- Spiro(9H-benzo(a)fluorene-9,2-b)pyridin)-3-o l, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octa deca hydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-
- Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-; Cyclopamine (8CI); Jervine, 11-deoxo- (7CI); Veratraman-3-ol, 17,23-epoxy-, (3ss,23ss)-; (-)-Cyclopamine; 11-Deoxojervine; 11-Deoxyjervine
- Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol, 1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-, (3S,3'R,3a'S,6'S,6aS,6bS,7a'R,9R,11aS,11bR)-
- Spiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b]pyridin]-3-ol,1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-octadecahydro-3',6',10,11b-tetramethyl-,(2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-